Literature DB >> 24677315

ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.

Jeffrey L Anderson, Paul A Heidenreich, Paul G Barnett, Mark A Creager, Gregg C Fonarow, Raymond J Gibbons, Jonathan L Halperin, Mark A Hlatky, Alice K Jacobs, Daniel B Mark, Frederick A Masoudi, Eric D Peterson, Leslee J Shaw.   

Abstract

Keywords:  AHA Scientific Statements; cost; quality indicators; quality measurement

Mesh：

Year:  2014        PMID： 24677315     DOI： 10.1161/CIR.0000000000000042

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  59 in total

1.  Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy.

Authors:  Dhruv S Kazi; Brandon K Bellows; Suzanne J Baron; Changyu Shen; David J Cohen; John A Spertus; Robert W Yeh; Suzanne V Arnold; Brett W Sperry; Mathew S Maurer; Sanjiv J Shah
Journal:  Circulation       Date:  2020-02-12       Impact factor: 29.690

2.  Drug Costs: What Can Infectious Diseases Physicians Do?

Authors:  Shashi N Kapadia; Roy M Gulick
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 5.226

3.  Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.

Authors:  Ankur Pandya; Stephen Sy; Sylvia Cho; Sartaj Alam; Milton C Weinstein; Thomas A Gaziano
Journal:  Med Decis Making       Date:  2017-05-10       Impact factor: 2.583

Review 4.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

Review 5.  Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care.

Authors:  Catherine G Derington; Jordan B King; Kelsey B Bryant; Blake T McGee; Andrew E Moran; William S Weintraub; Brandon K Bellows; Adam P Bress
Journal:  Curr Hypertens Rep       Date:  2019-11-07       Impact factor: 5.369

6.  Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.

Authors:  Junxiu Liu; Dariush Mozaffarian; Tom Gaziano; Renata Micha; Stephen Sy; Yujin Lee; Parke E Wilde; Shafika Abrahams-Gessel
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-06-04

7.  Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk.

Authors:  Ciaran N Kohli-Lynch; Brandon K Bellows; George Thanassoulis; Yiyi Zhang; Mark J Pletcher; Eric Vittinghoff; Michael J Pencina; Dhruv Kazi; Allan D Sniderman; Andrew E Moran
Journal:  JAMA Cardiol       Date:  2019-10-01       Impact factor: 14.676

8.  Cost-effectiveness of hypertension therapy according to 2014 guidelines.

Authors:  Andrew E Moran; Michelle C Odden; Anusorn Thanataveerat; Keane Y Tzong; Petra W Rasmussen; David Guzman; Lawrence Williams; Kirsten Bibbins-Domingo; Pamela G Coxson; Lee Goldman
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

9.  Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States.

Authors:  Emily P Hyle; Justine A Scott; Paul E Sax; Lucia R I Millham; Caitlin M Dugdale; Milton C Weinstein; Kenneth A Freedberg; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

10.  Cervical Cancer Screening-Moving From the Value of Evidence to the Evidence of Value.

Authors:  George F Sawaya
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.